 Home > Active Ingredient News > Study of Nervous System > Horde Biosciences completes A++ round of financing, Yuansheng Venture Capital leads the investment

Horde Biosciences completes A++ round of financing, Yuansheng Venture Capital leads the investment

 Last Update: 2021-06-12
 Source: Internet
 Author: User

Tags

technology infographic

2009 technology

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, a cutting-edge company dedicated to advancing disease treatment through human induced pluripotent stem cell technology-Hodder Biosciences announced that it has completed nearly 100 million yuan in A++ round of financing, led by Yuansheng Venture Capital, and original shareholders Longmen Capital and Huacheng Venture Capital Follow the vote.

Hodder Biotechnology was established in 2017, and the company's founder and chief executive officer (CEO) is Dr.

The company's first clinical product, hNPC01, is a human forebrain neural precursor cell product for the treatment of diseases such as stroke and brain injury.

Public information shows that Horde Biosciences has successively obtained angel round financing from Hangzhou Capital, Heli Investment, and Cybernaut; A round of financing led by Datai Capital and co-invested by Ruisheng Investment of Zhongguancun Dongsheng Science and Technology Park, and Longmen Capital and Huacheng Venture Capital invested tens of millions of yuan in A+ round of financing.

It is worth mentioning that, just a few days ago, Hodder Biosciences announced that it has reached a strategic partnership with the ophthalmic gene therapy development company-Nuforth Biosciences to jointly develop human iPSC-derived cell products for the treatment of eye diseases.

Mr.

Currently, treatments for neurological diseases are very limited, and there are huge unmet clinical needs.

▽ attention [drug Mingkang Germany ] micro-channel public number

[Medical attention Mingkang Germany ] ] micro-channel public number

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.